Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMBULATE DFU II: TTAX01 for Complex Diabetic Foot Ulcers
NCT04450693Phase 3Completed
- Sponsor
- BioTissue
- Start
- Nov 2020
- Primary completion
- Mar 2025
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
A Phase 3 trial of TTAX01 in diabetic foot ulcer (DFU), sponsored by BioTissue. Started Nov 2020; status: completed.
02
Drugs
TTAX01
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT04450693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04450693.